Literature DB >> 20425204

Intravenous lidocaine and mexiletine in the management of trigeminal autonomic cephalalgias.

Michael J Marmura1.   

Abstract

Lidocaine and mexiletine are class 1B antiarrhythmic drugs that act on sodium channels. Lidocaine is also an important anesthetic and topical agent that is useful in the treatment of multiple pain disorders, and mexiletine is commonly used for neuropathic pain and myotonia. Both intravenous lidocaine and mexiletine are increasingly used to treat pain syndromes and appear to be particularly effective in neuropathic pain. This suggests a role for these agents in patients with headache disorders. This article describes the role of intravenous lidocaine and mexiletine in the management of headache and trigeminal autonomic cephalalgias based on the published literature to date and provides practical guidelines for their use.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20425204     DOI: 10.1007/s11916-010-0098-6

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  64 in total

1.  Multicenter randomized trial and a systematic overview of lidocaine in acute myocardial infarction.

Authors:  Z P Sadowski; J H Alexander; B Skrabucha; A Dyduszynski; J Kuch; E Nartowicz; G Swiatecka; D F Kong; C B Granger
Journal:  Am Heart J       Date:  1999-05       Impact factor: 4.749

2.  SUNCT syndrome. Atypical temporal patterns.

Authors:  J A Pareja; J Joubert; O Sjaastad
Journal:  Headache       Date:  1996-02       Impact factor: 5.887

3.  Effect of mexiletine on thermal allodynia and hyperalgesia in diabetic mice.

Authors:  J Kamei; K Zushida
Journal:  Jpn J Pharmacol       Date:  2000-09

4.  Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA)--a prospective clinical study of SUNCT and SUNA.

Authors:  Anna S Cohen; Manjit S Matharu; Peter J Goadsby
Journal:  Brain       Date:  2006-08-11       Impact factor: 13.501

5.  Treatment of intractable painful diabetic neuropathy with intravenous lignocaine.

Authors:  Vanessa Viola; Harvey H Newnham; Richard W Simpson
Journal:  J Diabetes Complications       Date:  2006 Jan-Feb       Impact factor: 2.852

6.  ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology.

Authors:  V Fuster; L E Rydén; R W Asinger; D S Cannom; H J Crijns; R L Frye; J L Halperin; G N Kay; W W Klein; S Lévy; R L McNamara; E N Prystowsky; L S Wann; D G Wyse; R J Gibbons; E M Antman; J S Alpert; D P Faxon; V Fuster; G Gregoratos; L F Hiratzka; A K Jacobs; R O Russell; S C Smith; W W Klein; A Alonso-Garcia; C Blomström-Lundqvist; G De Backer; M Flather; J Hradec; A Oto; A Parkhomenko; S Silber; A Torbicki
Journal:  J Am Coll Cardiol       Date:  2001-10       Impact factor: 24.094

Review 7.  Trigeminal autonomic cephalalgias: current and future treatments.

Authors:  Anna S Cohen; Manjit S Matharu; Peter J Goadsby
Journal:  Headache       Date:  2007-06       Impact factor: 5.887

Review 8.  Pharmacology, electrophysiology, and pharmacokinetics of mexiletine.

Authors:  R L Woosley; T Wang; W Stone; L Siddoway; K Thompson; H J Duff; I Cerskus; D Roden
Journal:  Am Heart J       Date:  1984-05       Impact factor: 4.749

9.  New insights into the definition and meaning of proarrhythmia during initiation of antiarrhythmic drug therapy from the Cardiac Arrhythmia Suppression Trial and its pilot study. The CAST and CAPS Investigators.

Authors:  D G Wyse; J Morganroth; R Ledingham; P Denes; A Hallstrom; L B Mitchell; A E Epstein; R L Woosley; R Capone
Journal:  J Am Coll Cardiol       Date:  1994-04       Impact factor: 24.094

10.  Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse.

Authors:  D R Williams; R J Stark
Journal:  Cephalalgia       Date:  2003-12       Impact factor: 6.292

View more
  3 in total

1.  SUNCT and SUNA: Recognition and Treatment.

Authors:  Juan A Pareja; Mónica Alvarez; Teresa Montojo
Journal:  Curr Treat Options Neurol       Date:  2013-02       Impact factor: 3.598

Review 2.  Trigeminal autonomic cephalalgias: beyond the conventional treatments.

Authors:  Sarah Miller; Manjit Matharu
Journal:  Curr Pain Headache Rep       Date:  2014

3.  Mexiletine as a treatment for primary erythromelalgia: normalization of biophysical properties of mutant L858F NaV 1.7 sodium channels.

Authors:  R Cregg; J J Cox; D L H Bennett; J N Wood; R Werdehausen
Journal:  Br J Pharmacol       Date:  2014-08-29       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.